UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

International journal of clinical practice (Esher), 2011-11, Vol.65 (11), p.1132-1140

2011

Volltextzugriff (PDF)

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

Diabetes, metabolic syndrome and obesity, 2012-01, Vol.5 (default), p.293-294

Al Sifri, Saud

2012

Volltextzugriff (PDF)

The hook effect in prolactin immunoassays

Saudi medical journal, 2004-05, Vol.25 (5), p.656

2004

Volltextzugriff (PDF)

The incidence of hypoglycaemia in Muslim patients Expedited with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

International journal of clinical practice (Esher), 2011, Vol.65 (11), p.1132-1140

2011

Volltextzugriff (PDF)

Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment

PloS one, 2014-01, Vol.9 (1), p.e84350-e84350

2014

Volltextzugriff (PDF)

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals

Journal of comparative effectiveness research, 2024-07, Vol.13 (7), p.e230155

2024

Volltextzugriff (PDF)

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Diabetes, obesity & metabolism, 2021-06, Vol.23 (6), p.1221-1231

2021

Volltextzugriff (PDF)

Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship

Infection control and hospital epidemiology, 2023-12, Vol.44 (12), p.1901-1908

2023

Volltextzugriff (PDF)

234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study

Saudi medical journal, 2023-01, Vol.44 (1), p.57-66

2023

Volltextzugriff (PDF)

Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial

Diabetes care, 2021-10, Vol.44 (10), p.2361-2370

2021

Volltextzugriff (PDF)

Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes

Diabetes research and clinical practice, 2018-04, Vol.138, p.35-43

2018

Volltextzugriff (PDF)

A Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide Modified Release during Fasting in Gulf Cooperation Council Countries: An Analysis from the International DIA-RAMADAN Study

Dubai Diabetes and Endocrinology Journal, 2022-09, Vol.28 (3), p.102-111

2022

Volltextzugriff (PDF)

Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence

Diabetes therapy, 2016-06, Vol.7 (2), p.221-240

2016

Volltextzugriff (PDF)

Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis

Diabetes therapy, 2024-09

2024

Volltextzugriff (PDF)

Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit

Advances in therapy, 2023-07, Vol.40 (7), p.2965-2984

2023

Volltextzugriff (PDF)

Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

Diabetes research and clinical practice, 2015-08, Vol.109 (2), p.226-232

2015

Volltextzugriff (PDF)

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version

Frontiers in nutrition (Lausanne), 2022-06, Vol.9, p.899393-899393

2022

Volltextzugriff (PDF)

Abstract #1305594: Real-Life Effectiveness and Care Patterns of Diabetes Management in Eastern Europe, Middle East, and Africa (RECAP-DM EEMEA STUDY)

Endocrine practice, 2022-12, Vol.28 (12), p.S14-S14

2022

Volltextzugriff (PDF)

Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study

Diabetes & metabolic syndrome clinical research & reviews, 2023-02, Vol.17 (2), p.102707-102707, Article 102707

2023

Volltextzugriff (PDF)

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with coronary heart disease in Saudi Arabia

Journal Of The Saudi Heart Association, 2018-10, Vol.30 (4), p.367-367

2018

Volltextzugriff (PDF)

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia

Saudi medical journal, 2018-07, Vol.39 (7), p.697-704

2018

Volltextzugriff (PDF)

A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN

Diabetes research and clinical practice, 2020-05, Vol.163, p.108154-108154, Article 108154

2020

Volltextzugriff (PDF)

Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas

Diabetes therapy, 2021-08, Vol.12 (8), p.2115-2132

2021

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(36)
Tagungsberichte
(1)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan

The hook effect in prolactin immunoassays

The incidence of hypoglycaemia in Muslim patients Expedited with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial

Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment

Phosphodiesterase type 5 inhibitors as treatment for erectile dysfunction: a webinar-based poll unveiling perceptions of healthcare professionals

Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial

Improving antimicrobial use through better diagnosis: The relationship between diagnostic stewardship and antimicrobial stewardship

234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial

749-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial Outside Europe

The prevalence of cardiovascular disease in adults with type 2 diabetes mellitus in Saudi Arabia - CAPTURE study

Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial

Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes

A Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide Modified Release during Fasting in Gulf Cooperation Council Countries: An Analysis from the International DIA-RAMADAN Study

Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence

Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis

Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit

Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach

The Transcultural Diabetes Nutrition Algorithm: A Middle Eastern Version

Abstract #1305594: Real-Life Effectiveness and Care Patterns of Diabetes Management in Eastern Europe, Middle East, and Africa (RECAP-DM EEMEA STUDY)

Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with coronary heart disease in Saudi Arabia

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia

A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN

Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas

Suchergebnisse filtern